Mylan

991 articles about Mylan

• U.S. Patent and Trademark Office Issues Mylan Inc.'s Specialty Division, Dey, L.P., Three Additional Patents Protecting Perforomist(R) Inhalation Solution

  1/12/2009

• Mylan Inc. to Present at the 27th Annual J.P. Morgan Healthcare Conference

  1/6/2009

• Mylan Inc.'s Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules

  12/30/2008

• Mylan Inc. Announces Move to NASDAQ Stock Market

  12/12/2008

• Mylan Inc., Novartis AG Agree on Femara Generic

  12/2/2008

• Mylan Inc. Confirms First-to-File Patent Challenge Relating to AMRIX(R)

  12/1/2008

• Mylan Inc. Receives Final FDA Approval for the Generic Version of the Antidepressant Sarafem(R) Pulvules(R) Capsules

  11/18/2008

• Mylan Inc. Gets Tentative FDA OK on Antidepressant

  11/17/2008

• Mylan Inc. Receives Final Approval for First-to-File Generic Version of Antiepileptic Keppra(R) and Launches Immediately

  11/4/2008

• Mylan Inc. Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008

  10/30/2008

• Mylan Inc. Declares Quarterly Preferred Stock Dividend

  10/30/2008

• Mylan Inc.'s Matrix First-to-File on Generic Version of Vfend(R) Antifungal

  10/29/2008

• Mylan Inc. Confirms First-to-File Patent Challenge Relating to Lescol(R)

  10/23/2008

• Mylan Inc. Receives Tentative FDA Approval for First-to-File Generic Version of Blood Pressure Drug Benicar HCT(R)

  10/22/2008

• Mylan Inc. Schedules Third Quarter Financial Results Conference Call and Live Webcast

  10/16/2008

• Mylan Inc. Announces $500 Million of Floating Rate Debt Swapped to Fixed Rates Exposure to Short-term LIBOR Rate Borrowings Reduced to Approximately $850 Million; Mylan Responds to Abnormal Trading Activity in its Shares

  10/9/2008

• Mylan Inc. Receives FDA Approval for Generic Version of Parkinson's Treatment Parcopa(R) ODT Represents Another Mylan First-to-Market Opportunity

  9/22/2008

• Mylan Inc. Says FDA Approves its Generic Risperdal

  9/16/2008

• Mylan Inc. Completes $575 Million Cash Convertible Note Offering, Including Exercise of Overallotment Option

  9/16/2008

• Mylan Inc. Seeks Buyer for 500-Employee Dey, L.P. Site in Napa

  9/10/2008